These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 2435855)

  • 1. Depression and Parkinson's disease: possible role of serotonergic mechanisms.
    Kostić VS; Djuricić BM; Covicković-Sternić N; Bumbasirević L; Nikolić M; Mrsulja BB
    J Neurol; 1987 Feb; 234(2):94-6. PubMed ID: 2435855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered serotonin metabolism in depressed patients with parkinson's disease.
    Mayeux R; Stern Y; Cote L; Williams JB
    Neurology; 1984 May; 34(5):642-6. PubMed ID: 6200801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship of serotonin to depression in Parkinson's disease.
    Mayeux R; Stern Y; Sano M; Williams JB; Cote LJ
    Mov Disord; 1988; 3(3):237-44. PubMed ID: 2461509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin and 5-hydroxyindoleacetic acid in CSF. Difference in Parkinson's disease and dementia of the Alzheimer's type.
    Volicer L; Direnfeld LK; Freedman M; Albert ML; Langlias PJ; Bird ED
    Arch Neurol; 1985 Feb; 42(2):127-9. PubMed ID: 2579625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonin impairment in CSF of PD patients, without an apparent clinical counterpart.
    Olivola E; Pierantozzi M; Imbriani P; Liguori C; Stampanoni Bassi M; Conti M; D'Angelo V; Mercuri NB; Stefani A
    PLoS One; 2014; 9(7):e101763. PubMed ID: 25036938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced plasma serotonin and 5-hydroxyindoleacetic acid levels in Parkinson's disease are associated with nonmotor symptoms.
    Tong Q; Zhang L; Yuan Y; Jiang S; Zhang R; Xu Q; Ding J; Li D; Zhou X; Zhang K
    Parkinsonism Relat Disord; 2015 Aug; 21(8):882-7. PubMed ID: 26028271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-Hydroxytryptophan-induced cortisol response and CSF 5-HIAA in depressed patients.
    Koyama T; Lowy MT; Meltzer HY
    Am J Psychiatry; 1987 Mar; 144(3):334-7. PubMed ID: 2435178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Affective disorders and aggression disorders: evidence for a common biological mechanism.
    van Praag HM
    Suicide Life Threat Behav; 1986; 16(2):103-32. PubMed ID: 2428139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonergic dysfunction in depression associated with Parkinson's disease.
    McCance-Katz EF; Marek KL; Price LH
    Neurology; 1992 Sep; 42(9):1813-4. PubMed ID: 1387464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonergic neurotransmission in early Parkinson's disease: a pilot study to assess implications for depression in this disorder.
    Beucke JC; Uhl I; Plotkin M; Winter C; Assion HJ; Endrass T; Amthauer H; Kupsch A; Juckel G
    World J Biol Psychiatry; 2010 Sep; 11(6):781-7. PubMed ID: 20586535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central serotonin metabolism and frequency of depression.
    van Praag HM; de Haan S
    Psychiatry Res; 1979 Dec; 1(3):219-24. PubMed ID: 95233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-HT and 5-HIAA in cerebrospinal fluid in depression.
    Gjerris A; Sørensen AS; Rafaelsen OJ; Werdelin L; Alling C; Linnoila M
    J Affect Disord; 1987; 12(1):13-22. PubMed ID: 2437171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and biochemical features of depression in Parkinson's disease.
    Mayeux R; Stern Y; Williams JB; Cote L; Frantz A; Dyrenfurth I
    Am J Psychiatry; 1986 Jun; 143(6):756-9. PubMed ID: 2424323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-Hydroxyindoleacetic acid in cerebrospinal fluid of patients with Parkinson's syndrome treated with L dopa.
    Johansson B; Roos BE
    Eur J Clin Pharmacol; 1971 Sep; 3(4):232-5. PubMed ID: 5151306
    [No Abstract]   [Full Text] [Related]  

  • 15. Coexisting dementia and depression in Parkinson's disease.
    Sano M; Stern Y; Williams J; Coté L; Rosenstein R; Mayeux R
    Arch Neurol; 1989 Dec; 46(12):1284-6. PubMed ID: 2480103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biogenic amine disturbances in cerebrospinal fluid in parkinsonism and unipolar depression: use of the probenecid method.
    Vanderheyden JE; Noel G; Mendlewicz J
    Neuropsychobiology; 1981; 7(3):137-51. PubMed ID: 6164951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tritiated imipramine binding. A peripheral marker for serotonin in Parkinson's disease.
    Sano M; Stanley M; Lawton A; Coté L; Williams J; Stern Y; Marder K; Mayeux R
    Arch Neurol; 1991 Oct; 48(10):1052-4. PubMed ID: 1718247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonin and dopamine disturbances in patients with unipolar depression and Parkinsonism.
    Mendlewicz J; Vanderheyden JE; Noel G
    Adv Exp Med Biol; 1981; 133():753-67. PubMed ID: 6172024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoamine metabolism and depression in Parkinson patients.
    Puite JK; Schut T; van Praag HM; Lakke JP
    Psychiatr Neurol Neurochir; 1973; 76(1):61-70. PubMed ID: 4699106
    [No Abstract]   [Full Text] [Related]  

  • 20. Behavioral manifestations of movement disorders. Parkinson's and Huntington's disease.
    Mayeux R
    Neurol Clin; 1984 Aug; 2(3):527-40. PubMed ID: 6085395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.